Riluzole for treating spasticity in patients with chronic traumatic spinal cord injury: Study protocol in the phase ib/iib adaptive multicenter randomized controlled RILUSCI trial.

MLA

Cotinat, Maëva, et al. “Riluzole for Treating Spasticity in Patients with Chronic Traumatic Spinal Cord Injury: Study Protocol in the Phase Ib/Iib Adaptive Multicenter Randomized Controlled RILUSCI Trial.” PloS One, vol. 18, no. 1, Jan. 2023, p. e0276892. EBSCOhost, https://doi.org/10.1371/journal.pone.0276892.

APA

Cotinat, M., Boquet, I., Ursino, M., Brocard, C., Jouve, E., Alberti, C., Bensoussan, L., Viton, J.-M., Brocard, F., & Blin, O. (2023). Riluzole for treating spasticity in patients with chronic traumatic spinal cord injury: Study protocol in the phase ib/iib adaptive multicenter randomized controlled RILUSCI trial. PloS One, 18(1), e0276892. https://doi.org/10.1371/journal.pone.0276892

Chicago

Cotinat, Maëva, Isabelle Boquet, Moreno Ursino, Cécile Brocard, Elisabeth Jouve, Corinne Alberti, Laurent Bensoussan, Jean-Michel Viton, Frédéric Brocard, and Olivier Blin. 2023. “Riluzole for Treating Spasticity in Patients with Chronic Traumatic Spinal Cord Injury: Study Protocol in the Phase Ib/Iib Adaptive Multicenter Randomized Controlled RILUSCI Trial.” PloS One 18 (1): e0276892. doi:10.1371/journal.pone.0276892.